Abiopharma

🔍 Hatoum Kamal Anthony (Executive)

Company: BBB FOODS INC (TBBB)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 16,003,914 shares of Class A Common Shares (Direct)
  Date: 2026-08-07 | Code: C | equity_swap_involved: false | shares_owned_after: 16,003,914.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F3
• Holds 0 shares of Class A Common Shares (Direct)
  Date: 2026-08-07 | Code: H | shares_owned_after: 630,000.00 | Footnotes: F1
• Sold 16,003,914 shares of Class C Common Shares (Derivative)
  Date: 2026-08-07 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F1, F2, F2, F2, F1, F3

Footnotes:

• F1: Includes vested and unvested restricted stock units ("RSUs") and other equity-linked awards.
• F2: On August 7, 2026 all of the Issuer's Class C Common Shares automatically converted into an equal number of Class A Common Shares and all vested and unvested RSUs and other equity-linked awards which were to settle in Class C Common Shares (including, in certain cases, upon the occurrence of time-based vesting events) became RSUs or other equity-linked awards that settle into Class A Common Shares (including, in certain cases, upon the occurrence of time-based vesting events).
• F3: The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
• REMARKS: Due to the Issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the Reporting Person's transactions in the Issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.